12:00 AM
 | 
Mar 29, 1999
 |  BC Week In Review  |  Clinical News  |  Regulatory

Glaxo Wellcome Inc. regulatory update

The FDA granted marketing approval for Glaxo's Wellferon interferon alfa-n1 to...

Read the full 32 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >